Detection of minimal residual disease after sex-mismatch bone marrow transplantation in chronic myelogenous leukemia by fluorescence in situ hybridization
- 30 April 1994
- journal article
- Published by Elsevier in Cancer Genetics and Cytogenetics
- Vol. 73 (2) , 130-133
- https://doi.org/10.1016/0165-4608(94)90196-1
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Clinical detection of BCR-ABL fusion by in situ hybridization in chronic myelogenous leukemiaCancer Genetics and Cytogenetics, 1993
- Detection of male cells in mixtures containing varying proportions of male and female cells by fluorescence in situ hybridization and G‐bandingCytometry, 1993
- Detection of trisomy 12 in chronic lymphocytic leukemia by fluorescence in situ hybridization to interphase cells: a simple and sensitive methodBlood, 1992
- Combined immunophenotyping and DNA in situ hybridization to study lineage involvement in patients with myelodysplastic syndromesBlood, 1992
- All advanced stage non-Hodgkin's lymphomas with a polymerase chain reaction amplifiable breakpoint of bcl-2 have residual cells containing the bcl-2 rearrangement at evaluation and after treatmentBlood, 1991
- Immunologic Purging of Marrow Assessed by PCR before Autologous Bone Marrow Transplantation for B-Cell LymphomaNew England Journal of Medicine, 1991
- Detection of bcr - abl Fusion in Chronic Myelogeneous Leukemia by in Situ HybridizationScience, 1990
- Detection of the Philadelphia chromosome in interphase nucleiCytogenetic and Genome Research, 1990
- Analysis of the origin of marrow cells in bone marrow transplant recipients using a Y-chromosome-specific in situ hybridization assayBlood, 1989
- MINIMAL RESIDUAL LEUKAEMIA IN CHRONIC MYELOID LEUKAEMIA PATIENTS AFTER T-CELL DEPLETED BONE-MARROW TRANSPLANTATIONThe Lancet, 1989